Hair isoniazid levels predict TB sputum culture conversion von Muzanyi, G., Ntale, M., Salata, R., Joloba, M., Mukonzo, J., Mafigiri, D., Mubiri, P., Bbosa, G.

Volltext

Facilitators and barriers to adolescent participation in a TB clinical trial von Mangan, J.M., Hedges, K.N.C., Salerno, M.M., Tatum, K., Bouwkamp, B., Frick, M.W., McKenna, L., Muzanyi, G., Engle, M., Coetzee, J., Yvetot, J., Elskamp, M., Lamunu, D., Tizora, M.E. Theunissen, Namutamba, D., Chaisson, R.E., Swindells, S., Nahid, P., Dorman, S.E., Kurbatova, E.

Volltext

Sputum smear-positive, culture-negative state during anti-tuberculosis treatment in the MGIT liquid culture era von Bark, C. M., Thiel, B. A., Ogwang, S., Sekitoleko, I., Muzanyi, G., Joloba, M. L., Johnson, J. L.

Volltext

Reasons for non-participation in an international multicenter trial of a new drug for tuberculosis treatment von Lamunu, D., Chapman, K. N., Nsubuga, P., Muzanyi, G., Mulumba, Y., Mugerwa, M. A., Goldberg, S., Bozeman, L., Engle, M., Saukkonen, J., Mastranunzio, S., Mayanja-Kizza, H., Johnson, J. L.

Volltext

Impact of directly observed sputum collection on sputum culture contamination rates von Muzanyi, G, Angel, M, Nakamate, T, Ogwang, S, Nyole, S

Volltext

Impact of directly observed sputum collection on sputum culture contamination rates von Muzanyi, G, Angel, M, Nakamate, T, Ogwang, S, Nyole, S

Volltext

Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium von Dorman, Susan E., Goldberg, Stefan, Stout, Jason E., Muzanyi, Grace, Johnson, John L., Weiner, Marc, Bozeman, Lorna, Heilig, Charles M., Feng, Pei-Jean, Moro, Ruth, Narita, Masahiro, Nahid, Payam, Ray, Susan, Bates, Edward, Haile, Betial, Nuermberger, Eric L., Vernon, Andrew, Schluger, Neil W.

Volltext

Short Communication: Impact of Directly Observed Sputum Collection on Sputum Culture Contamination Rates von Muzanyi, G, Angel, M, Nakamate, T, Ogwang, S, Nyole, S

Volltext

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis von Dorman, Susan E, Nahid, Payam, Kurbatova, Ekaterina V, Phillips, Patrick P.J, Bryant, Kia, Dooley, Kelly E, Engle, Melissa, Goldberg, Stefan V, Phan, Ha T.T, Hakim, James, Johnson, John L, Lourens, Madeleine, Martinson, Neil A, Muzanyi, Grace, Narunsky, Kim, Nerette, Sandy, Nguyen, Nhung V, Pham, Thuong H, Pierre, Samuel, Purfield, Anne E, Samaneka, Wadzanai, Savic, Radojka M, Sanne, Ian, Scott, Nigel A, Shenje, Justin, Sizemore, Erin, Vernon, Andrew, Waja, Ziyaad, Weiner, Marc, Swindells, Susan, Chaisson, Richard E

Volltext

Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment von De Groote, Mary A, Nahid, Payam, Jarlsberg, Leah, Johnson, John L, Weiner, Marc, Muzanyi, Grace, Janjic, Nebojsa, Sterling, David G, Ochsner, Urs A

Volltext

Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis von Nahid, Payam, Bliven-Sizemore, Erin, Jarlsberg, Leah G, De Groote, Mary A, Johnson, John L, Muzanyi, Grace, Engle, Melissa, Weiner, Marc, Janjic, Nebojsa, Sterling, David G, Ochsner, Urs A

Volltext

Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349) von Pettit, April C, Phillips, Patrick P J, Kurbatova, Ekaterina, Vernon, Andrew, Nahid, Payam, Dawson, Rodney, Dooley, Kelly E, Sanne, Ian, Waja, Ziyaad, Mohapi, Lerato, Podany, Anthony T, Samaneka, Wadzanai, Savic, Rada M, Johnson, John L, Muzanyi, Grace, Lalloo, Umesh G, Bryant, Kia, Sizemore, Erin, Scott, Nigel, Dorman, Susan E, Chaisson, Richard E, Swindells, Susan

Volltext

Elucidating Novel Serum Biomarkers Associated with Pulmonary Tuberculosis Treatment. e61002 von Groote, Mary ADe, Nahid, Payam, Jarlsberg, Leah, Johnson, John L, Weiner, Marc, Muzanyi, Grace, Janjic, Nebojsa, Sterling, David G, Ochsner, Urs A

Volltext